Kimihiko Takada

431 citations
19 papers · 334 indexed · h-index 12

Kimihiko Takada

19 papers receiving 332 citations

Peers

Kimihiko Takada
Comparison fields: 5 of 67
  • Internal Medicine 23
  • Hematology 55
  • Endocrinology 23
  • Complementary and alternative medicine 32
  • Biochemistry 22
Replace Sheryl R. Bowley with:
Sheryl R. Bowley United States
Guangpu Xue China
Asuman Mutlu Canada
Alexander R. Stainer United Kingdom
Ha‐Yong Yoon South Korea
P. Singh India
Pei Yu China
Demokritos Tsoukatos Greece
Ae Ran Moon South Korea
Shuangfeng Xie China
Kimihiko Takada relative to Sheryl R. Bowley United States Sheryl R. Bowley's profile →
Citations per field
00.5×7.7×
Sheryl R. Bowley · 1×
Citations per year

Countries citing papers authored by Kimihiko Takada

Since Specialization
Citations

This map shows the geographic impact of Kimihiko Takada's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kimihiko Takada with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kimihiko Takada more than expected).

Fields of papers citing papers by Kimihiko Takada

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kimihiko Takada. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kimihiko Takada. The network helps show where Kimihiko Takada may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Kimihiko Takada, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Kimihiko Takada Line = papers co-authored together Kimihiko Takada links everyone, so they are left out of the graph.

All Works

19 of 19 papers shown
#Work
1 20241
2 202013
3 201912
4 201538
5 201527
6 20153
7 20136
8 20128
9 20127
10 20097
11 200830
12 200615
13 200346
14 200229
15 200020
16
Verotoxin-1 induces tissue factor expression in human umbilical vein endothelial cells through activation of NF-kappaB/Rel and AP-1.
200029
17 19961
18 199126
19 198716

About Kimihiko Takada

Kimihiko Takada is a scholar working on Endocrinology, Hematology and Internal Medicine, having authored 19 papers that have together received 334 indexed citations. Recurring topics across this work include Blood Coagulation and Thrombosis Mechanisms (4 papers), Cell death mechanisms and regulation (3 papers), Immune Response and Inflammation (3 papers), Bioactive Compounds in Plants (2 papers), Natural product bioactivities and synthesis (2 papers), Cancer therapeutics and mechanisms (2 papers), Signaling Pathways in Disease (2 papers) and Cancer-related Molecular Pathways (2 papers). The work is most often cited by research in Internal Medicine (23 citations), Hematology (55 citations) and Endocrinology (23 citations). Kimihiko Takada has collaborated with scholars based in Japan. Frequent co-authors include Hidemi Ishii, Toshiyuki Higuchi, Junichi Kitajima, Yutaka Masuda, Junichi Sugiyama, Yutaka Masuda, Koji Oida, Shuichi Horie, Hiroyuki Ishikawa and Maki Ishii. Their work appears in journals such as Blood, Biochemical Pharmacology and Toxicology and Applied Pharmacology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026